Stock listing
ILMN Stock Price, News, Filings & Events — Illumina, Inc.
Selected listing: ILMN · NASDAQ · USD · US
This page tracks Illumina, Inc.'s ILMN:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ILMN:NASDAQ. ILMN:NASDAQ is the stock-level entry point for investors researching Illumina, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Illumina, Inc. is a leading company in the field of genomics, specializing in DNA sequencing and array-based solutions. Based in the United States, Illumina has a market capitalization of approximately $29.37 billion. The company focuses on advancing the understanding of genetics and improving healthcare through innovative technologies.
- Ticker
- ILMN:NASDAQ
- Asset type
- Stock
- Market cap
- $33.13B
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NASDAQ
- Currency
- USD
Illumina, Inc. ILMN:NASDAQ stock context
This page tracks Illumina, Inc.'s ILMN:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ILMN:NASDAQ. ILMN:NASDAQ is the stock-level entry point for investors researching Illumina, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Illumina, Inc. is a leading company in the field of genomics, specializing in DNA sequencing and array-based solutions. Based in the United States, Illumina has a market capitalization of approximately $29.37 billion. The company focuses on advancing the understanding of genetics and improving healthcare through innovative technologies.
Latest news from Illumina, Inc.
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026
July 30, 2026
Illumina expands Billion Cell Atlas program with new AI drug developers
July 16, 2026
Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026
July 9, 2026
Illumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal Officer
July 9, 2026
Daniel M. Skovronsky, MD, PhD, appointed to Illumina's Board of Directors
June 23, 2026
Research Illumina, Inc.
Illumina, Inc. investor report
Review AI stock analysis and investor report context for ILMN:NASDAQ.
Illumina, Inc. company profile
View the public company page for Illumina, Inc. on 6ix.
Illumina, Inc. news
Read company news and market updates connected to Illumina, Inc..
Illumina, Inc. investor events
Find investor webinars, events, and replay context for Illumina, Inc..
Alternate listings
ILU:GETTEX
DE · EUR
Alternate listing for Illumina, Inc.; the primary context on this page is ILMN:NASDAQ.
ILU:TRADEGATE
DE · EUR
Alternate listing for Illumina, Inc.; the primary context on this page is ILMN:NASDAQ.
1ILMN:MIL
IT · EUR
Alternate listing for Illumina, Inc.; the primary context on this page is ILMN:NASDAQ.
927079:LSX
DE · EUR
Alternate listing for Illumina, Inc.; the primary context on this page is ILMN:NASDAQ.
ILMN:BMV
MX · MXN
Alternate listing for Illumina, Inc.; the primary context on this page is ILMN:NASDAQ.
ILU:FWB
DE · EUR
Alternate listing for Illumina, Inc.; the primary context on this page is ILMN:NASDAQ.
927079:LS
DE · EUR
Alternate listing for Illumina, Inc.; the primary context on this page is ILMN:NASDAQ.
I1LM34:BMFBOVESPA
BR · BRL
Alternate listing for Illumina, Inc.; the primary context on this page is ILMN:NASDAQ.
0J8Z:LSE
GB · USD
Alternate listing for Illumina, Inc.; the primary context on this page is ILMN:NASDAQ.
ILU:SWB
DE · EUR
Alternate listing for Illumina, Inc.; the primary context on this page is ILMN:NASDAQ.
4ILMN:EUROTLX
IT · EUR
Alternate listing for Illumina, Inc.; the primary context on this page is ILMN:NASDAQ.
ILU:HAN
DE · EUR
Alternate listing for Illumina, Inc.; the primary context on this page is ILMN:NASDAQ.